Sector valuations Celltrion, Inc.

Equities

End-of-day quote Korea S.E. Other stock markets 2025-12-05			5-day change	1st Jan Change
183,300.00 ^KRW	+0.38%		-1.03%	+1.67%

Dec. 02	Celltrion Announces U.S. FDA Approval of 300mg strength of OMLYCLO®?	CI
Nov. 27	Celltrion, Inc. Receives Health Canada Approval for Eydenzelt®?, a Biosimilar Confirming Eylea®? (aflibercept 2Mg)	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	Price to Book (Y)	PEG (Y)	EV / Sales (Y)	EV / EBITDA (Y)	EV / EBIT (Y)	Dividend Yield (Y)	Capi.($)
CELLTRION, INC.	51.29x	2.27x	0.63x	9.9x	27.99x	36.4x	0.4%	27.13B
LONZA GROUP AG	38.11x	3.93x	0.62x	5.55x	18.74x	27.34x	0.91%	48.03B
IQVIA HOLDINGS INC.	31.66x	6.03x	-6.13x	3.19x	13.77x	21.58x	-.--%	38.3B
BEONE MEDICINES AG	106.47x	9.17x	-0.71x	6.49x	65.17x	100.81x	-.--%	36.67B
MEDPACE HOLDINGS, INC.	36.8x	36.74x	2.14x	5.95x	27.03x	28.32x	-.--%	15.35B
REVOLUTION MEDICINES, INC.	-14.06x	9.56x	-0.25x	5482.71x	-13.3x	-13.09x	-.--%	15.17B
ICON PUBLIC LIMITED COMPANY	28.76x	1.52x	-0.89x	2.13x	10.89x	12.12x	-.--%	14.19B
TEMPUS AI, INC.	-51.36x	33.47x	0.67x	11.07x	28502.9x	-205.63x	-.--%	13.58B
IONIS PHARMACEUTICALS, INC.	-36.33x	48.12x	1.4x	13.77x	-39.3x	-34.45x	-.--%	13.25B
ASCENDIS PHARMA A/S	-52.87x	1375.83x	1.1x	15.07x	-123.59x	-89.45x	-.--%	12.74B
EUROFINS SCIENTIFIC SE	23.17x	2.03x	0.59x	1.93x	8.78x	13.45x	1.08%	12.2B
QIAGEN N.V.	24.5x	2.72x	0.06x	5.07x	13.72x	17.12x	0.44%	10.21B
BIO-TECHNE CORPORATION	49.51x	4.55x	0.28x	8.04x	22.68x	24.73x	0.5%	9.9B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	43.89x	2.57x	0.02x	2.75x	11.4x	13.87x	-.--%	9.06B
ABIVAX	-33.64x	14.52x	35.32x	1382.2x	-35.59x	-34.39x	-	8.22B
PHARMARON BEIJING CO., LTD.	29.47x	3.41x	-11.42x	3.62x	14.93x	23.46x	0.71%	6.88B
HANGZHOU TIGERMED CONSULTING CO., LTD	30.69x	1.9x	0.13x	5.7x	22.45x	24.54x	1.04%	5.67B
Average	18.00x	91.67x	1.39x	409.71x	1,679.33x	-1.96x	0.32%	17.44B
Weighted average by Cap.	29.56x	68.95x	0.23x	324.83x	1,316.57x	12.04x	0.31%